(2022) demonstrated that hyperbaric oxygen (HBO) therapy combined with teniposide enhances the efficacy of PD-1 antibodies by alleviating tumor hypoxia and augmenting chemotherapy-induced DNA damage-mediated STING activation. The gene discussed is STING1; the disease is neoplasm.